Logo
A

ArteraAI

123 employees

Our AI can prognosticate patient outcomes & personalize treatment in localized prostate cancer. Five Phase III randomized trials were used to develop prognostic and predictive AI biomarkers.

Investor insights

Funding rounds participated in

$20M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Hospitals and Health Care

Sectors

Hospitals and Health Care

Funding rounds raised

Total raised

$20M

from investors over 1 rounds

A

ArteraAI raised $20M on March 1, 2024

FAQ